AZ Taps India's Torrent to Add Branded Generics in Emerging Markets
This article was originally published in PharmAsia News
Executive Summary
LONDON - To extend its reach in emerging markets, AstraZeneca PLC today said it had signed an agreement with India's Torrent Pharmaceuticals Ltd. for the rights to sell 18 undisclosed generic drugs in nine territories
You may also be interested in...
Soriot Effect Sees AstraZeneca Selectively Scale Back Branded Generics In Emerging Markets
Leadership change is forcing the Anglo-Swedish drug giant to review its priorities in the branded generics business. AstraZeneca will invest selectively in countries where it has built a high base and shows ability to post robust growth.
As Pfizer Deal Speeds Up, Aurobindo Pairs Up With AstraZeneca For Branded Generics Play In Emerging Markets
India's Aurobindo Pharma is turning out to be a partner of choice for Big Pharma companies that intend to dig aggressively into emerging markets with a branded generics product portfolio.
As Pfizer Deal Speeds Up, Aurobindo Pairs Up With AstraZeneca For Branded Generics Play In Emerging Markets
India's Aurobindo Pharma is turning out to be a partner of choice for Big Pharma companies that intend to dig aggressively into emerging markets with a branded generics product portfolio.